Management | Page 7 of 74 | SpiritIndia.com

Multiple Sclerosis :: Accentia announces investigational new drug application for Revimmune for refractory MS

Accentia Biopharmaceuticals announces that it met with the Food and Drug Administration (FDA) on September_26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune™. The FDA has indicated its support for Accentia to submit an IND for a pivotal Phase 3 randomized controlled, multi-center clinical trial of Revimmune, the company’s potential therapeutic for refractory, relapsing-remitting Multiple Sclerosis (MS).

Blood Pressure :: Women with high or increasing blood pressure are up to three times more likely to develop diabetes

One of the largest studies to investigate the relationship between blood pressure and type 2 diabetes has found that women who have high blood pressure levels are three times more likely to develop diabetes than women with low blood pressure levels. This effect was independent of body mass index and other conditions that are known to predispose people to cardiovascular disease and diabetes.

Medicaid :: Patients in Medicaid managed care programs may receive lower-quality care than commercial programs

Medicaid managed care enrollees appear to receive lower-quality care than patients enrolled in commercial managed care programs, according to a study in the Oct. 10 issue of JAMA.

Health :: Medical identity theft – the importance of protecting your health records

Many consumers take precautions against identity theft, but what about medical identity theft? In addition to financial peril, victims can suffer physical danger if false entries in medical records lead to the wrong treatment.

Cancer :: David H. Koch gives $100 million to MIT for cancer research

MIT has announced a $100 million gift from Koch Industries executive and MIT alumnus David H. Koch that will usher in new paradigms in highly integrative cancer research. The gift will bring together MIT scientists and engineers under one roof to develop new and powerful ways to detect, diagnose, treat, and manage this often deadly disease.

Tuberculosis :: New initiative to address TB drug shortage

The Stop TB Partnership’s Global Drug Facility and UNITAID announced a collaboration with 19 countries to address life-threatening shortages of anti-tuberculosis drugs.

Heart :: Central nervous system infections rare but devastating following heart transplantation

Central nervous system infections develop infrequently following heart transplants but are a significant predictor of death, according to an article posted online today that will appear in the December 2007 print issue of Archives of Neurology, one of the JAMA/Archives journals.

Diabetes :: New IDF guidelines raise importance of post-meal glucose control

The International Diabetes Federation (IDF) has published new guidelines on the contribution and impact of post-meal glucose in diabetes disease management at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) on September_19, 2007. The IDF recognises the growing evidence that post-meal glucose is a key contributor to overall glycaemic control – particularly with respect to HbA1C levels, and that reducing post-meal glucose has a significant impact on the risk of developing diabetic complications.

Cancer :: New guide on palliative care services for people living with advanced cancer

WHO today releases its first guide on planning palliative care services for people living with advanced stages of cancer. The guide, which is based on consultations with more than 70 leading cancer experts in the world, has identified highly effective low-cost public health models to care for terminally ill cancer patients, especially in developing countries.

Prostate Cancer :: Using additional biopsy-scoring data may help determine prostate cancer prognosis

Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the Oct. 3 issue of JAMA.